| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 30.65B | 28.66B | 24.97B | 27.78B | 23.85B | 23.03B |
| Gross Profit | 8.35B | 8.05B | 6.06B | 6.13B | 5.79B | 7.19B |
| EBITDA | 9.20B | 9.06B | 5.36B | 5.28B | 4.66B | 6.39B |
| Net Income | 6.49B | 6.24B | 4.56B | 4.56B | 3.37B | 5.11B |
Balance Sheet | ||||||
| Total Assets | 56.18B | 53.11B | 48.61B | 43.49B | 42.13B | 36.85B |
| Cash, Cash Equivalents and Short-Term Investments | 27.45B | 25.04B | 16.87B | 13.73B | 12.16B | 13.64B |
| Total Debt | 14.80B | 12.93B | 12.26B | 9.31B | 10.72B | 6.72B |
| Total Liabilities | 19.22B | 17.25B | 15.74B | 12.73B | 14.35B | 9.58B |
| Stockholders Equity | 36.96B | 35.85B | 32.87B | 30.75B | 27.77B | 27.28B |
Cash Flow | ||||||
| Free Cash Flow | 3.33B | 3.40B | 4.14B | 3.39B | 1.41B | 3.45B |
| Operating Cash Flow | 5.66B | 5.27B | 5.23B | 4.63B | 3.59B | 5.75B |
| Investing Cash Flow | -5.67B | -3.47B | -1.38B | -371.33M | -6.41B | -2.56B |
| Financing Cash Flow | 225.56M | -2.65B | 333.22M | -3.91B | 1.32B | 33.59M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | HK$78.32B | 6.02 | 17.82% | 4.31% | 15.93% | 20.70% | |
78 Outperform | HK$47.07B | 10.31 | 21.66% | 6.15% | 5.51% | 3.90% | |
71 Outperform | HK$17.60B | 10.91 | 14.30% | 5.87% | 14.76% | 23.04% | |
63 Neutral | HK$2.28B | 1.52 | 14.74% | 12.14% | -0.95% | 2.58% | |
63 Neutral | HK$1.72B | 2.63 | 12.81% | 7.98% | 13.52% | 4.95% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
47 Neutral | HK$1.64B | 6.53 | 4.73% | 8.06% | -2.44% | -5.98% |